| CPC A61M 37/0015 (2013.01) [A61K 9/0021 (2013.01); A61K 31/164 (2013.01); A61K 31/17 (2013.01); A61K 31/728 (2013.01); A61K 36/63 (2013.01); A61K 36/886 (2013.01); A61K 38/39 (2013.01); A61M 2037/0023 (2013.01)] | 12 Claims |
|
1. An applicator system comprising a microneedle array for use for the intradermal delivery of a first active ingredient, the applicator system comprising:
a plurality of microneedles on a carrier, wherein the microneedles are made of a polymer matrix in which at least one second active ingredient for wound healing is integrated or incorporated;
a trigger mechanism; and
at least one reservoir for storing the first active ingredient, the reservoir being in connection to the microneedles; and
wherein the first active ingredient is different from the at least one second active ingredient for wound healing, and the first active ingredient is a medicinal drug;
wherein the at least one second active ingredient for wound healing is selected from the group consisting of dexpanthenol, collagen, hyaluronic acid, and combinations thereof; and
wherein the polymer of the polymer matrix is selected from the group consisting of polylactides, polyglycolides, polylactide-co-glycolides, polyanhydrides, poly(ortho)esters, polyurethanes, polybutyric acids, polyvaleric acids, polylactide-co-caprolactones, polycarbonates, polyesters, polyvinyl chloride, polyacrylamides, cycloolefin (co)polymers, polymethacrylates, and thermoplastics.
|